Hudson Bay Capital Management »

Evommune shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 51k 22.99

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management
BlackRock

View all funds holding Evommune